Results 201 to 210 of about 7,239,102 (288)

Si(OTeF5)4 – A Strong, Homoleptic Pentafluoroorthotellurate‐Based Lewis Superacidic Silane

open access: yesChemistry – A European Journal, EarlyView.
The homoleptic pentafluoroorthotellurate‐based silane Si(OTeF5)4 was synthesized and fully characterized via spectroscopic techniques. The Lewis superacidic properties were investigated theoretically as well as experimentally and its utilization as a Lewis acid is demonstrated by the reaction with nitrogen bases.
Friederike Oesten   +5 more
wiley   +1 more source

C‐Terminal Functionalization Methods of Amino Acids, Peptides, and Proteins

open access: yesChemistry – A European Journal, EarlyView.
C‐terminal functionalization offers powerful routes to peptide and protein diversification, yet epimerization, hydrolysis, and selectivity remain key challenges. This Review surveys enzymatic, decarboxylative, and condensation strategies, highlighting advances toward chemo‐ and regioselective, protecting‐group‐free, atom‐efficient methods applicable to
Jay Hanssens   +3 more
wiley   +1 more source

Acceptability of community health worker-led hypertension care with independent prescribing in rural Lesotho: a mixed- methods study

open access: yes
Lejone TI   +22 more
europepmc   +1 more source

High Fatigue‐Resistant Photoswitches Based on iridium(III)‐DTE Systems

open access: yesChemistry – A European Journal, EarlyView.
Coordination to iridium(III) enhances fatigue resistance over multiple photoswitching cycles in diarylethenes. This metal coordination modulates photoresponse relative to the free ligands under identical irradiation conditions, opening new avenues for practical applications.'' ABSTRACT A series of four differently substituted nonsymmetrical ...
Ariadna Pazos   +6 more
wiley   +1 more source

Exposure–Response Analysis of Enfortumab Vedotin Plus Pembrolizumab as First‐Line Therapy for Locally Advanced or Metastatic Urothelial Cancer

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Enfortumab vedotin is a nectin‐4‐directed antibody–drug conjugate currently approved in combination with pembrolizumab for the first‐line treatment of locally advanced or metastatic urothelial cancer. Here we describe the exposure–response relationship between enfortumab vedotin exposures and efficacy/safety endpoints in patients who received ≥1 dose ...
Vaishali L. Chudasama   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy